Lexpos News

NHS England has published an invitation to tender (ITT) inviting community pharmacy owners interested in providing a Community Pharmacy Respiratory Syncytial Virus (RSV) and Pertussis Vaccination Enhanced Service. Announcement of the tender, follows on from the September 2024 introduction of the RSV vaccination programme in general practice and NHS trusts and the initial commissioning of [...]

The post Provision of RSV and Pertussis vacs from May 2025 appeared first on Community Pharmacy England.

Community Pharmacy England met with 50 MPs and parliamentary staff at the Houses of Parliament yesterday (Tuesday 11th March) to discuss the vital healthcare role that pharmacies play in local communities and how the critical pressures on community pharmacies are putting this at risk. During the busy Westminster event MPs were asked to support the call to protect [...]

The post Strong support for pharmacy at Parliamentary event appeared first on Community Pharmacy England.

This recall notification has been updated since its initial publication on 11 March 2025 to include the correct information in relation to the safety updates in the Patient Information Leaflet (PIL) and the changes that have been made in line with reference product PIL. MHRA Class 4 Medicines Notification: Azithromycin 250 mg Capsules (Jubilant Pharmaceuticals [...]

The post Update – MHRA Class 4 Medicines Defect Notification: Azithromycin 250 mg Capsules (Jubilant Pharmaceuticals NV) appeared first on Community Pharmacy England.

Multi-Factor Authentication (MFA) is becoming mandatory for all NHSmail users. The NHSmail team previously announced that users would be prompted to enable MFA from late 2024, and a rollout timeline was introduced to support this transition. This initiative follows earlier announcements (from 2023 onwards) about NHSmail MFA becoming a mandatory requirement. What is MFA? Previously, you [...]

The post Reminder: Mandatory NHSmail Multi-Factor Authentication for all users appeared first on Community Pharmacy England.

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Salbutamol (Salamol Easi-Breathe®) 100micrograms/dose breath actuated inhaler CFC free MSN/2025/014 Tier 2 – medium impact Date of issue: 06/03/2025 Salbutamol (Salamol Easi-Breathe®) 100micrograms/dose breath actuated inhaler CFC free is out of stock until late March 2025. Salbutamol pressurised metered-dose inhalers (pMDIs) [...]

The post Medicine Supply Notification: Salbutamol (Salamol Easi-Breathe®) 100micrograms/dose breath actuated inhaler CFC free appeared first on Community Pharmacy England.